OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
March 02, 2021
The rapid and efficient delivery of innovative treatments through the COVID-19 pandemic has demonstrated the value of collaborations within the bio/pharma industry.
February 02, 2021
Outsourcing partners can provide a multitude of advantages in the development of drug delivery solutions, including those designed for targeted patient populations.
January 03, 2021
The right partner can help companies overcome key formulation challenges for biologic drugs.
October 03, 2020
More complex and challenging compounds require a more tailored approach to formulation strategies.
August 01, 2020
Contract service providers offer vital services to bio/pharma companies of all sizes. Establishing an effective working relationship and managing operations are key to avoiding compliance issues.
July 21, 2020
Catalent has unveiled plans to invest in a European center of excellence for clinical biologics formulation development and drug product fill/finish services at its facility in Limoges, France.
July 08, 2020
The acquisition will give the CDMO additional clinical filling options in Europe, which is expected to come online in 2021.
July 06, 2020
Lonza is making additional investments in its global particle engineering network for expanded capacity and specialized capabilities.
July 02, 2020
Demand for custom drug delivery solutions is increasing and bringing forth an exciting period of valuable, innovative development opportunities.
The COVID-19 pandemic has created a rise in demand for R&D and a shift in focus for some contract organizations.